American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
Amir N, Beard C, Cobb M, Bomyea J. Attention modification program in individuals with generalized anxiety disorder. Journal of Abnormal Psychology 2009 February; 118(1): 28-33.
Arehart-Treichel J. Anxiety symptoms linked to women’s cardiac events. Psychiatric News 2009 December; 44(24): 26-37.
Arehart-Treichel J. Extended GAD treatment keeps relapse rates low. Psychiatric News 2011 February; 46(3): 24.
Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalized anxiety disorder: systematic review and meta-analysis. British Medical Journal 2011 March; 342.
Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, et al. Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. Journal of Clinical Psychiatry 2001; 62(suppl 11): 53-58.
Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatric Clinics of North America 2009 September; 32(3): 483-524.
Blumenthal H, Leen-Feldner EW, Babson KA, Gahr JL, Trainor CD, Frala JL. Elevated social anxiety among early maturing girls. Developmental Psychology 2011 July; 47(4): 1133-1140.
Bystritsky A, Kerwin L, Feusner JD, Vapnik T. A pilot controlled trial of buproprion XL vs. escitalopram in generalized anxiety disorder (GAD). Pscychopharmacology Bulletin 2008; 41(1): 1-9.
Cuthbert B. Early prevention in childhood anxiety disorders. American Journal of Psychiatry 2010; 167:1428-1430.
Fava M, Asnis GM, Shrivastava R, Lydiard B, et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. Journal of Clinical Psychopharmacology 2009 June; 29(3): 222-230.
Flint A, Peasley-Miklus C, Papademetriou E, et al. Effect of age on the frequency of anxiety disorders in major depression with psychotic features. American Journal of Geriatric Psychiatry 2010 May; 18 (5): 404-412.
Grant BF, Hasin DS, Blanco C, Stinson FS, et al. The epidemiology of social anxiety disorder in the United States: results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 2005 November; 66(11): 1351-1361.
Hammond DC. Hypnosis in the treatment of anxiety- and stress-related disorders. Expert Review of Neurotherapy 2010 February; 10(2): 263-273.
Herring MP, O’Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systemic review. Archives of Internal Medicine 2010 February; 170(4): 321-331.
Johnson JG, Cohen P, Pine DS, et al. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. Journal of the American Medical Association 2000; 284: 2348-2351.
Kalra SK, Swedo SE. Children with obsessive-compulsive disorder: are they just “little adults?” Journal of Clinical Investigation 2009; 119(4): 737-746.
Merikangas KR, He JP, Brody D, Fisher PW, et al. Prevalence and treatment of mental disorders among U.S. children in the 2001-2004 NHANES. Pediatrics 2010 January; 125(1): 75-81.
McLaughlin KA, Hatzenbuehler ML. Stressful life events, anxiety sensitivity, and internalizing symptoms in adolescents. Journal of Abnormal Psychology 2009 August; 118(3): 659-669.
Nasreen HE, Kabir ZN, Forsell Y, Edhborg M. Low birth weight in offspring of women with depressive and anxiety symptoms during pregnancy: results from a population based study in Bangladesh. Biomed Central Public Health 2010; 10: 515.
Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, et al. Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology 2000 August; 20(4): 467-471.
Piacentini J, Roblek T. Recognizing and treating childhood anxiety disorders. Western Journal of Medicine 2002 May; 176(3): 149-151.
Pincus DB, May JE, Whitton SW, Mattis SG, Barlow DH. Cognitive-behavioral treatment of panic disorder in adolescence. Journal of Clinical Child and Adolescent Psychology 2010 Sep; 39(5): 638-49.
Rapee RM. The development and modification of temperamental risk for anxiety disorders: prevention of a lifetime of anxiety? Biological Psychiatry 2002 November; 52(10): 947-957.
Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. American Journal of Psychiatry 2000; 157: 968-974.
Saeed SA, Bloch RM, Antonacci DJ. Herbal and dietary supplements for treatment of anxiety disorders. American Family Physician 2007 Aug 15; 76(4): 549-56.
Soto JA, Dawson-Andoh NA, BeLue R. The relationship between perceived discrimination and generalized anxiety disorder among African Americans, Afro Caribbeans and non-Hispanic Whites. Journal of Anxiety Disorders 2011 March; 25(2): 258-265.
Trivedi JK, Gupta PK. An overview of Indian research in anxiety disorders. Indian Journal of Psychiatry 2010; 52(7): 210-218.
White SW, Ollendick T, Scahill L, Oswald D, Albano AM. Preliminary efficacy of a cognitive-behavioral treatment program for anxious youth with autism spectrum disorders. Journal of Autism and Developmental Disorders 2009 June.